Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NGR-hTNF + BIC in Advanced Malignant Pleural Mesothelioma
NCT01098266Phase 3Completed
- Sponsor
- AGC Biologics
- Start
- Apr 2010
- Primary completion
- Apr 2014
- Modality
- Peptides, Fc-Fusion Proteins
- Countries
- 12
01
Overview
A Phase 3 trial of NGR-TNF in malignant pleural mesothelioma (MPM), sponsored by AGC Biologics. Started Apr 2010; status: completed.
02
Drugs
NGR-TNF
03
Conditions
malignant pleural mesothelioma (MPM)
Beyond the preview
Go deeper on NCT01098266.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01098266.